ArticleDrug and alcohol dependence2010
Subjective effects to marijuana associated with marijuana use in community and clinical subjects.
Article in Drug and alcohol dependence, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Initial Drug Sensitivity and Vulnerability to Substance Use Disorders: A Review of Individual Influences.Biology · 2026Review
- Cannabis modalities matter for momentary subjective drug effects.Addictive behaviors · 2026Article
- Etiology of longitudinal associations between subjective effects and substance use disorders in a clinical sample.Addictive behaviors reports · 2026Article
- Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Current topics in behavioral neurosciences · 2026Review
- Variability of total THC in greenhouse cultivated dried Cannabis.Scientific reports · 2025Article
- Subjective drug-effect ratings predict cannabis self-administration in people who use cannabis daily.The Journal of pharmacology and experimental therapeutics · 2025Article
- The association between cannabis and alcohol co-use and momentary subjective effects: Risks for increasingly hazardous cannabis use.Drug and alcohol dependence · 2025Article
- The mediating role of PERMA in the relationship between social role engagement and drug use problems among veterans with mental illness.Frontiers in psychiatry · 2025Article
- The effects of simultaneous alcohol and cannabis use on subjective drug effects: A narrative review across methodologies.Alcohol, clinical & experimental research · 2024Review
- Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.Molecules (Basel, Switzerland) · 2024Review
- Subjective effects as predictors of substance use disorders in a clinical sample: A longitudinal study.Drug and alcohol dependence · 2023Article
- Predictive impact of different acute cannabis intoxication effects with regard to abstinence motivation and cessation of use.Scientific reports · 2023Article
- Use of a Novel EEG-Based Objective Test, the CognalyzerNeurology and therapy · 2022Article
- Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.Psychophysiology · 2022Article
- Alcohol Use Motives and Cannabis Use among Young Adults: Between- and Within-Person Associations Based on Monthly Data from a Community Sample.Substance use & misuse · 2022Article
- A positive psychology framework for why people use substances: Implications for treatment.Frontiers in psychology · 2022Article
- Mu opioid receptor gene variant modulates subjective response to smoked cannabis.American journal of translational research · 2022Article
- Which came first: Cannabis use or deficits in impulse control?Progress in neuro-psychopharmacology & biological psychiatry · 2021Review
- Subjective effects of combustible, vaporized, and edible cannabis: Results from a survey of adolescent cannabis users.Drug and alcohol dependence · 2020Observational
- Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes.Journal of cannabis research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionMarijuana is the most commonly used illicit drug among adolescents. Marijuana use induces both psychological and physiological responses, which can be interpreted by an individual in a variety of ways (i.e. subjective effects). We have examined subjective effects in adolescent, young adult community, and clinical populations to determine how patterns of use may be predicted by an individual's subjective experiences with the drug.
methodParticipants were community and clinical sample subjects drawn from the Colorado Center of Antisocial Drug Dependence (CADD) and a sample of adjudicated youth from the Denver metropolitan area (aged 11-30). They were evaluated with the Composite International Diagnostic Interview-Substance Abuse Module (CIDI-SAM) and the Lyons battery for subjective effects. Scales for subjective effects were created using Mokken scale analysis. Multivariate linear and logistic regression was used to examine associations between the subjective scales and marijuana outcomes.
resultsMokken scaling revealed two subjective effects scales, positive and negative. Both scales were significantly positively associated with marijuana abuse or dependence in both the community and clinical sample and regular use in the community sample. The negative scale was negatively associated with past six-month use in the community sample (p<0.05) and clinical sample, after controlling for age and gender effects.
conclusionsThese findings suggest that diverse subjective experiences with marijuana can be ordered hierarchically and that the resulting short scales can be used in either clinical or community settings. Further, they suggest that the potential for marijuana use problems is related to the type of subjective experience from marijuana exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.